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Abstract
Background: B-cell lymphomas are thought to reflect different stages of B-cell maturation. Based
on cytogenetics and molecular markers, mantle cell lymphoma (MCL) is presumed to derive
predominantly from naïve, pre-germinal centre (pre-GC) B lymphocytes. The aim of this study was
to develop a method to investigate the similarity between MCL cells and different B-cell
compartments on a protein expression level.
Methods: Subpopulations of B cells representing the germinal centre (GC), the pre-GC mantle
zone and the post-GC marginal zone were isolated from tonsils using automated magnetic cell
sorting (AutoMACS) of cells based on their expression of CD27 and IgD. Protein profiling of the
B cell subsets, of cell lines representing different lymphomas and of primary MCL samples was
performed using top-down proteomics profiling by surface-enhanced laser detection/ionization
time-of-flight mass spectrometry (SELDI-TOF-MS).
Results: Quantitative MS data of significant protein peaks (p-value < 0.05) separating the three B-
cell subpopulations were generated. Together, hierarchical clustering and principal component
analysis (PCA) showed that the primary MCL samples clustered together with the pre- and post-
GC subpopulations. Both primary MCL cells and MCL cell lines were clearly separated from the B
cells representing the GC compartment.
Conclusion: AutoMACS sorting generates sufficient purity to enable a comparison between
protein profiles of B cell subpopulations and malignant B lymphocytes applying SELDI-TOF-MS.
Further validation with an increased number of patient samples and identification of differentially
expressed proteins would enable a search for possible treatment targets that are expressed during
the early development of MCL.
Introduction
In the last decade, several studies of lymphomas have
been performed using microarray analysis of global gene
expression [1]. Genomic profiling has proven to be of
both diagnostic and prognostic value. However, the corre-
lation between mRNA and protein expression is generally
poor, and regulation of many physiological processes is
post-transcriptional. Protein analysis is therefore essential
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lymphoma formation. Proteomic profiling using liquid
chromatography-MS/MS has been applied to a limited
number of lymphomas of different origin [2]. The high
throughput top-down method of SELDI-TOF-MS, which
is based on chip-binding of intact proteins and endog-
enous peptides, has been used to differentiate follicular
lymphoma from Burkitt's lymphoma [3] and to distin-
guish between diffuse large B-cell lymphoma, follicular
lymphoma and mantle cell lymphoma (MCL) [4]. This
method is optimal for the detection of peptides or small
proteins in the mass range of 1000-25000 Daltons [5].
Many proteins and peptides that have regulatory roles in
proliferation, differentiation, apoptosis and cell signaling
are found within this range.
Each stage in the B cell maturation process is characterized
by a particular structure of the B cell receptor and expres-
sion patterns of differentiation markers, e.g. the pre-ger-
minal centre (GC) marker IgD or the post-GC marker
CD27 (Fig. 1). During the process, which involves dou-
ble-stranded DNA breaks and rearrangements, there is a
potential for malignant transformation. The differentia-
tion markers can therefore be used to characterize differ-
ent human B cell lymphomas, that appear to be "frozen"
at the different development stages [6].
We have applied this approach in the comparison of MCL
cells with subpopulations of normal B lymphocytes. MCL
is a relatively rare malignancy that represents 5-10% of all
non-Hodgkins lymphomas [7]. Although several genetic
and molecular mechanisms involved in the pathogenesis
of MCL have been defined, there is currently no effective
standard treatment for the disease, and the clinical out-
come is poor [7,8]. While most human B-cell lymphomas
are derived from cells at the GC or post-GC stage of devel-
opment [9], MCL has been thought to originate from
naïve, pre-GC B cells [10]. However, approximately 20%
of the MCL cells, which are abundant in the mantle zone
of lymphoid follicles [11], have undergone somatic
hypermutations in the immunoglobulin variable heavy-
chain genes, suggesting a heterogeneous origin [10].
In the present study, we used SELDI-TOF-MS to generate
expression profiles of intact proteins and peptides. MCL
cells and cell lines representing other B cell malignancies
were compared with subpopulations of B-cells represent-
ing the three major compartments of peripheral lymphoid




This study was approved by the Ethics committee at Karo-
linska Institutet, Etikkommitté syd, #689/03.
Cell lines and primary MCL
The MCL cell lines Jvm-2 [12,13], Rec-1 [14,15], Granta
519 [16] and JeKo-1 [17], the precursor leukemia cell line
Nalm-6 [18] representing the pre-GC stage, the Burkitt's
lymphoma cell lines Radji [19] and Namalwa [20] repre-
senting GC and the plasma cell line SKMM-2 [21,22] rep-
resenting post-GC were used in the study. All cell lines
were tested for mycoplasma and were found to be free
from infection. The tests were performed with MycoAlert
Mycoplasma Detection Kit (LT07-218, Cambrex, USA) on
a Thermo Luminoskan Ascent (Thermo Fischer Scientific,
Inc, USA). The cell lines were cultured in RPMI 1640
GlutaMaxtm-1 (72400-021, Invitrogen, USA), supple-
mented with 10% FBS (16140-071, Invitrogen, USA) and
50 μg/mL gentamicin (15750-045, Invitrogen, USA) at
37°C using a 5% CO2 atmosphere, except JeKo-1, which
was cultured using a 20% FBS supplement. The cells were
harvested in the exponential phase, snap frozen in liquid
nitrogen and stored as pellets at -70°C. In addition, two
primary MCL tumors, with confirmed t(11;14)(q13;q32)
cyclin D1 translocation and immunophenotype of CD5+/
CD23-, indicative of MCL [8], were included in the study.
The primary MCL tumours contained >80% tumor cells,
as verified using the CD5 and CD23 markers in a FACScan
(BD, USA) (not shown). Biological triplicates were used
for the primary cells except MCL tumours, that were ana-
lyzed in duplicate due to lack of availability of samples.
Isolation of B cell populations from healthy individuals
The normal B cell populations were extracted from fresh
tonsils obtained from patients undergoing tonsillecto-
mies at the surgical department, Karolinska University
Hospital, Huddinge. The tonsils were dissected and then
homogenized using a Medimachine (Dako Denmark A/S,
Glostrup, Denmark). The resulting cell suspension was
purified from erythrocytes by treatment with a lysis buffer
The three major B cell compartments in peripheral lymphoid organsFi ure 1
The three major B cell compartments in peripheral 
lymphoid organs. Presence of the differentiation markers 
CD27 and IgD in each zone of a B cell follicle is indicated.
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quent filtration to remove cellular debris. The B cell pop-
ulation was separated from T cells by negative selection.
The pan T cell CD3+ surface receptor was conjugated with
magnetic anti-CD3+ microbeads (130-050-101, Miltenyi
Biotec, Germany), which were sorted by an AutoMACS
sorter (Miltenyi Biotec, Germany) using column 130-021-
101 (Miltenyi Biotec, Germany). The purity of the T and B
cell fractions was validated by using the pan B cell surface
receptor CD19+ [6] and the T cell CD3+ receptor. The B cell
fractions were >90% CD19+ as determined by incubating
with fluorescent CD3+/FITC + CD19+/RPE antibodies
(FR866, DAKO, Denmark) and analyzing with a FACScan
(BD, USA) (not shown). The total B cell extracts were snap
frozen in liquid nitrogen and stored as pellets at -70°C.
Isolation of B cell subpopulations representing pre-GC, GC 
and post-GC
In order to separate pre-GC, GC and post-GC populations
from the tonsils, the total B cell populations from the
AutoMACS separation were incubated with magnetic
CD27+ microbeads (130-051-601, Miltenyi Biotec, Ger-
many), generating a post-GC CD27+ population and a
CD27- population consisting of both pre-GC and GC B
cells. The CD27- population was then further sorted using
an anti-IgD+-FITC antibody and Anti-FITC microbeads
(130-048-701, Miltenyi Biotec, Germany), to isolate the
pre-GC and GC fractions.
Protein preparation and concentration determination
Cell pellets from cell lines and isolated primary B cell pop-
ulations were subjected to a lysis buffer (150 mM NaCl,
50 mM Tris-HCL pH 7,5, 0,1% Triton X-100, 1% CHAPS)
and repeatedly immersed in liquid nitrogen to lyse the
cells and release the proteins. Protein concentrations were
determined using a BCA protein assay kit (23225,
PIERCE, USA) according to the manufacturer's instruc-
tions.
Analysis of proteins using SELDI-TOF
The samples were dissolved to a final concentration of
0.15 ug/ul in 50 mM ammonium acetate pH 4.5 and 0.1%
Triton X-100. 100 μl of the prepared protein solutions
were analyzed using a cation exchange (CM 10, pH 4,5)
protein-chip (Biorad Inc., USA) [23]. Standard protocols
recommended by the manufacturer were used in the
experiments. Mass spectra were collected using SELDI-
TOF Protein Biology System IIC using three different laser
intensity and time lag focusing settings creating three data
sets; 3-6 kDa, 6-10 kDa and 10-40 kDa (optimization of
M/Z regions and of time lag focusing). The design of the
experimental protocol was based on pilot experiments, to
optimize peak number and minimize detector saturation
from intense peaks at 5 kDa and 9 kDa. The data analysis
was performed using CE software package Ciphergen Bio-
systems, CA, USA. All spectra were baseline corrected and
peak detection was performed using signal/noise value of
3 and a valley depth of value of 2 (first pass).
Statistical analysis
The significant differentially expressed protein peaks were
identified using nonparametric t-test, using in pair-wise
comparison Mann-Whitney and in group-wise compari-
son Kruskal Wallis test. The peaks with p-value < 0,05
were considered as significant differentially expressed pro-
teins peaks.
Clustering of protein profiles
Unsupervised hierarchical clustering of the primary popu-
lations and cell lines was performed using all peaks
detected within each mass range. To distinguish between
pre-GC, GC and post-GC populations, all peaks detected
within the three populations which had p-value < 0,05
were considered significant and were used to cluster these
primary populations within each data set. The corre-
sponding peaks in the primary MCL samples and MCL cell
lines were then included to generate a hierarchical cluster-
ing of MCL samples within the pre-GC, GC and post-GC
populations. The peaks were analyzed by heat map and
principal component analysis (PCA). Ciphergen Express
software, Ciphergen, CA, USA, was used for both hierar-
chical clustering and PCA.
Results
Isolation of B cell subpopulations representing pre-GC, GC 
and post-GC
B lymphocytes were isolated from tonsils by negative
AutoMACS selection and elimination of T cells expressing
the CD3+ surface receptor. The purity of the B cell fraction
was >90% as determined using the CD19+ B cell marker
(data not shown). In order to isolate viable subpopula-
tions of B lymphocytes representing different stages of the
maturation process, the total B cell population was incu-
bated with magnetic CD27+ microbeads. Histograms of
the cells before (Fig. 2A) and post-sorting (Fig. 2B-D) are
shown. The AutoMACS separation resulted in a CD27+
population representing post-GC cells (Fig. 2B), and a
CD27- population consisting of both pre-GC and GC B
cells. Using the anti-IgD+-FITC antibody and targeting
anti-FITC microbeads to the fluorophore of the primary
antibody, the IgD+ pre-GC (Fig. 2C) and IgD- GC (Fig. 2D)
populations could be separated. This procedure generated
viable cells with a purity of 67% in the CD27- IgD- popu-
lation, 69% in the CD27- IgD+ population and 83%
(67+16%) in the CD27+ population (Fig. 2).
Hierarchical clustering and principal component analysis 
of primary cells and cell lines
In order to clarify the possible similarity between MCL
cells and the purified subpopulations of B cells represent-Page 3 of 8
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filing was performed. Hierarchical clustering is an
unsupervised method that allows data to self-organize
according to similarity between samples. In this study the
method was applied with respect to protein expression
pattern. The different stages of B cell maturation were rep-
resented by the AutoMACS-sorted B-cell subpopulations
and by the precursor leukemia cell line Nalm-6 (pre-GC),
the Burkitt's lymphoma cell lines Raji and Namalwa (GC)
and the plasma cell line SKMM-2 (post-GC). MCL was
represented by two primary MCL samples, MCA A and
MCL B, and the MCL cell lines Jvm-2, Rec-1, Granta 519
and JeKo-1. In addition, a sample denoted NOEK was
analyzed. This consisted of cells derived from MCL B that
had been kept in culture under the same conditions as the
other cell lines. Within the 3-10 kDa range, the samples
clustered into two main groups (Fig 3A, upper panel).
One of the groups contained the primary MCL samples,
NOEK and the MCL cell lines Rec-1 and Jvm-2 together
with the B cell subpopulations representing pre-GC. The
remaining cell lines and B cell subpopulations clustered
together in the other group. Except for Rec-1 and Jvm-2,
the cell lines did not cluster according to their presumed
origin. This phenomenon was even more pronounced in
the 6-15 kDa range (Fig. 3B, lower panel), where the cell
lines and the primary B lymphocytes formed separate
clusters.
In order to increase the sensitivity and specificity of the
analysis, peaks that significantly (p-value < 0.05) sepa-
rated the primary pre-GC, GC and post-GC populations
were selected. The analysis was performed in the 6-15 kDa
area, since the number of peaks in the 3-10 kDa area was
too low using this approach. In the subsequent analysis,
the subpopulations representing pre- and post-GC clus-
tered more closely to each other than to the GC subpopu-
lations (Fig. 4A). The primary MCL sample MCL-B and the
cultured primary MCL cells NOEK clustered together with
the pre-GC subpopulations, while MCL-A clustered
together with the GC subpopulation (Fig. 4A). However,
in PCA, a cluster comprising the pre-GC subsets and all
MCL samples was observed (Fig. 4B). When cell lines were
included in the hierarchical clustering, all MCL cell lines
except one triplicate of Jvm-2 clustered together with the
plasma cell line SKMM-2 (Fig. 5a). Similar to the results in
Fig. 3b, the cell lines used in this analysis formed a cluster
that was separate from the cluster comprising the primary
cells. MCL-B, NOEK and one of the Jvm-2 triplicates clus-
tered together with the pre-GC subsets, while MCL-A clus-
tered together with the post-GC subpopulations (Fig. 5a).
FACScan images showing the different sub-populations of B cells before and after AutoMACS sortingigure 2
FACScan images showing the different sub-populations of B cells before and after AutoMACS sorting. (A) The 
total B cell population before CD27 separation. (B) The CD27+ population representing post-GC. (C) TheCD27-/IgD+ popula-
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Proteome Science 2009, 7:43 http://www.proteomesci.com/content/7/1/43The primary MCL clustered together with the pre- and
post-GC subsets in PCA, while both MCL cell lines and
primary MCL were clearly separated from the GC subpop-
ulation (Fig. 5b).
Discussion
In the present study, we used AutoMACS sorting in order
to isolate subpopulations of B cells reflecting the pre-GC,
GC and post-GC stage. In the subsequent analysis of pro-
tein expression, the cation exchange protein-chip array
CM 10 was used at pH 4,5. A previous study including
MCL samples has shown that the same chip surface
resulted in detection of the highest number of peaks [4].
In the initial analysis, the primary MCL samples A and B
clustered together with the pre-GC subpopulations in the
3-10 kDa range. Two of the MCL cell lines, Rec-1 and Jvm-
2, clustered together with the primary MCL, while Granta
519 and JeKo did not. Using global gene expression anal-
ysis, the MCL cell lines Granta 519, SP53 and NCEB1 have
earlier been shown to cluster closely to primary MCL sam-
ples [24]. Overall, the other cell lines did not cluster
together with the B cell subpopulations they were sup-
posed to represent, based on their origin. In the 6-15 kDa
range, all of the cell lines clustered together, indicating the
presence of proteins that show similar expression levels
exclusively in the cell lines, despite their different origin.
One factor influencing the expression pattern could be
cell culture conditions. However, the NOEK population of
primary MCL cells that had been cultured under identical
conditions to the MCL cell lines for one week did not clus-
ter together with them. Neither is EBV-transformation
likely to account for the similarity of the cell lines in the
6-15 kDa range, as both the JeKo-1 and Rec-1 cell lines,
which clustered together with the other cell lines, are EBV-
negative. This observation indicates that studies based on
cell lines must be interpreted with caution and emphasize
Hierarchical clustering of B cell sub-populations, cell lines and MCL patient samplesFigure 3
Hierarchical clustering of B cell sub-populations, cell lines and MCL patient samples. The three subpopulations are 
labeled as follows: CD 27+ (green, post-GC), CD 27-/IgD+ (red, pre-GC) and CD 27-/IgD- (blue, GC). The two primary MCL 
samples are depicted in dark pink, and the cultured primary MCL cells NOEK in light pink. The MCL cell lines are depicted in 
turquoise and the remaining cell lines in grey. Clustering within the (A) 3-10 kDa and (B) 6-15 kDa ranges.
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Hierarchical clustering and principal component analysis within the 6-15 kDa area of peaks that significantly (p-value < 0.05) separated the B c ll sub-po ulationsFigure 4
Hierarchical clustering and principal component analysis within the 6-15 kDa area of peaks that significantly 
(p-value < 0.05) separated the B cell sub-populations. (A) Cluster analysis of the three subpopulations CD 27+ (green, 
post-GC), CD 27-/IgD+ (red, pre-GC) and CD 27-/IgD- (blue, GC). The two primary MCL samples (dark pink) and the cultured 
primary MCL cells NOEK (light pink) were included in the analysis. (B) PCA plot representing the same samples and peaks as 
in (A).
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Hierarchical clustering and principal component analysis within the 6-15 kDa area of peaks that significantly (p-value < 0.05) separated the B c ll sub-po ulationsFigure 5
Hierarchical clustering and principal component analysis within the 6-15 kDa area of peaks that significantly 
(p-value < 0.05) separated the B cell sub-populations. (A) Cluster analysis of the three subpopulations CD 27+ (green, 
post-GC), CD 27-/IgD+ (red, pre-GC) and CD 27-/IgD- (blue, GC). In addition to the two primary MCL samples (dark pink) and 
the cultured primary MCL cells NOEK (light pink), MCL cell lines (turquoise) and a plasma cell line (grey) were included in the 
analysis. (B) PCA plot representing the same samples and peaks as in (A).
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Proteome Science 2009, 7:43 http://www.proteomesci.com/content/7/1/43the need to analyze patient samples in order to under-
stand the biology behind diseases. In an extensive gene
expression study using 60 cell lines of different origin, it
has earlier been shown that the majority of the cell lines
were poor representatives of their cellular origin [25].
The subpopulations of the biological triplicates from ton-
sil that were labeled with the same set of antibodies clus-
tered together when peaks that significantly distinguished
the subpopulations (p-value < 0,05) were analyzed fol-
lowing SELDI-TOF-MS. Thus, the purity of the subpopula-
tions following AutoMACS sorting was sufficient to
generate reproducible protein profiles from each stage.
The GC-population clustered separately from the pre-GC
and post-GC populations. This could reflect up-regulation
of the expression of specific proteins required for GC mat-
uration and down-regulating of others. When separating
the post-GC CD27+ population using CD27+ microbeads,
the post-GC fraction contained mostly CD27+/IgD-, but
also 10-25% CD27+/IgD+ B cells representing early mem-
ory cells. IgD is a pre-GC marker, and the presence of IgD+
early memory cells might also influence the clustering
together of the pre-GC and post-GC populations.
In the hierarchical clustering and PCA of peaks that signif-
icantly (p < 0.05) distinguished the B cell subsets, the pri-
mary MCL samples and the cultured primary MCL cells
NOEK clustered together with the pre- and post-GC sub-
populations. The similarity between MCL cells and pre-
GC cells is in accordance with the prevailing assumptions
about the pathology of MCL [10]. However, the present
study needs to be expanded in order to determine if pro-
teome profiling using SELDI-TOF-MS supports a pre-GC
or heterogeneous origin of MCL cells. Interestingly, the
GC subpopulations were clearly separated from both the
primary MCL samples and the MCL cell lines in PCA.
Thus, it appears as if the biology of MCL cells differs from
that of B cells residing in the GC compartment.
In conclusion, this pilot study has shown that purifying B
lymphocytes using AutoMACS-sorting combined with
profiling of intact proteins using SELDI-TOF-MS allows a
comparison to be made between the protein expression of
MCL cells and subpopulations of B-cells representing the
three major compartments of peripheral lymphoid
organs. Further studies based on a larger patient cohort
and followed by MS-based identification of proteins may
contribute to the understanding of the molecular patho-
genesis of MCL and other B cell malignancies, and con-
ceivably suggest new potential treatment targets.
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